Access to healthcare
Everyday health
Living every day with COPD
Over 1.4 million Australians are living with Chronic Obstructive Pulmonary Disease, or COPD, with as many as one in 20 people over the age of 55 affected by the condition. Although understanding of COPD has improved significantly in recent years, we are constantly seeking new avenues to explore in our relentless pursuit for better breathing.
How we do business
Pulling back the curtain on the PBS
GSK and ViiV Healthcare aim to ‘pull back the curtain’ on the PBS with a video and report that explain how the Government assesses new medicines and vaccines.
Everyday health
Digital healthcare attitudes in Australia
How we do business
PharmAus 2017: Showcasing the health and economic benefits of innovation in medicines
The inaugural PharmAus showcase saw GSK and 19 other innovative pharmaceutical companies illustrate our industry’s investment and collaboration with Australia’s top research institutes, universities, biotechs and patients, to deliver the latest breakthroughs in treatment.
Access to healthcare
No 'silver bullet' to tackle this disease
Dr Sophie Biernaux, talks about GSK's commitment to fighting malaria.
Innovation
Bioelectronics
GSK's Bioelectronics R&D unit is pursuing a relatively new scientific field that could one day result in a new class of medicines that would not be pills or injections but miniaturised, implantable devices.
Access to healthcare
Giving babies a healthier start
Why are our scientists researching how to adapt an ingredient in mouthwash into a gel for newborn babies?
How we do business
Open source: the future of medical discovery
There is growing recognition that no single research body or group has the know-how or resources to tackle the most widespread and persistent diseases. Fortunately, a growing number of scientists are engaged in open source innovation that removes barriers and creates a more transparent environment for medical discovery.
How we do business
Crowd sourcing new treatments for malaria
New medicines are urgently needed for diseases of the developing world and those medicines need to be affordable.
Innovation
Australian innovation pilot aims to reduce cost of vaccination in developing world
GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.
Access to healthcare
The fight against malaria
For the past 30 years, GSK scientists have been working with other organisations across the globe with the aim to develop what could be the world’s first malaria vaccine.
How we do business
Fostering excellence in respiratory research
GSK has been a significant supporter of The George Institute for Global Health for a number of years and we’ve recently contributed $161,000 to support a research fellow in respiratory medicine.
Environment
Reducing our carbon footprint
Reducing our carbon footprint while addressing health access in neighbouring, less developed countries.
Our Community
Volunteering in Kenya
Through GSK’s PULSE Volunteer Partnership, our employees can use their professional skills to help create sustainable change for our non-profit partners and the communities they serve.
Our Community
NYSF - inspiring the next generation of scientists
With much of the world’s future innovation to come from science, technology, engineering and maths (STEM), it is very important that the innovators of tomorrow are supported and mentored.
Our Community
Polio Australia - support of polio retreat to help those affected
Polio is a disease that has virtually been forgotten by our community. Although vaccination implemented in Australia in the late 1950s has prevented new infections, polio survivors form the largest single physical disability group in the country.
Everyday health
Every breathe you take: Alannah's story
Most of us take breathing for granted. It’s an automatic activity that we don’t need to think about. But imagine if every breath you took was a struggle; imagine waking up in the night wheezing and short of breath.
Our Community
Employees helping communities
Our people and the communities in which they operate are essential to our success. We focus on building their individual capabilities and aim to support and empower them to be the best they can be.
Everyday health
Keep moving - Jan's story
Jan was diagnosed with osteoarthritis after noticing aches and pains while swimming and carrying out my daily activities. Jan shares how this osteoarthritis has affected her life and how she manages the pain and inflammation brought about by this condition.
Our people
Laura Ljubanovic
Laura talks about her experience stepping up from legal counsel to Head of the Legal Department at GSK Australia on International Women's Day 2016.
Environment
Trusted partnership achieves supply chain improvements
When we received feedback that the number of cooler boxes used for distribution of our vaccines was excessive we worked with our partner to find a solution.
Everyday health
Living with COPD: Peter's story
Can you imagine what it would feel like to take a breath when your lungs were already full of air? This is a feeling people with Chronic Obstructive Pulmonary Disease (COPD) may live with every day of their lives.
Access to healthcare
International collaboration seeks to make childbirth safer in developing countries
A global alliance led by GSK and Monash University promises to fast-track delivery of oxytocin to mothers in developing countries
Our Community
Save the Children
GSK and Save the Children have the goal of helping to save the lives of one million children by sharing medical and humanitarian expertise.
Our people
Karyn and Ahmed Trek for Kids
Two employees from Australia and New Zealand join 38 of their global colleagues to Trek for Kids in support of Save the Children in Ethiopia